Clinical trial Recruiting at 2 sites Observational

Registry for patients with anomalous aortic origin of coronary arteries

Official title: EUROAAOCA Registry

Run by University of Padova · NCT06089902 · Data updated 2026-11-12

This study is collecting information from patients with a rare heart condition called anomalous aortic origin of coronary arteries to see how different treatments work and improve care for everyone.

More Congenital Heart Disease trials

Quick facts

Study typeObservational
SexAll
Enrollment500 (estimated)
SponsorUniversity of Padova
Academic / other
Locations2 sites (Padova, PD and 1 other locations)
StatusRecruiting
StartedJanuary 1, 2019
Main results expectedJanuary 1, 2025
Study endsJanuary 1, 2029
Registry record updatedOctober 19, 2023
Trial IDNCT06089902 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this registry are patients diagnosed with AAOCA, whether they are referred for surgical intervention or medical follow-up.

Probably not a fit

Patients with isolated high-coronary take-off, anomalous origin of a circumflex from the right coronary artery, or major congenital heart diseases may not benefit from this registry.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The European Registry for Anomalous Aortic Origin of Coronary Arteries (EURO-AAOCA) aims to collect and analyze data on patients diagnosed with AAOCA to improve management strategies across different medical centers. This observational study will gather baseline demographic information, symptoms, and procedural details from participating centers, ensuring patient anonymity. The registry will help identify variations in treatment approaches and outcomes, ultimately guiding better clinical practices for this rare congenital heart defect.

Why it matters

Potential benefit: If successful, this registry could lead to improved management and outcomes for patients with anomalous aortic origin of coronary arteries.

How similar studies have gone: Other registries focusing on congenital heart defects have shown success in improving patient management and outcomes, suggesting a positive outlook for this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All patients with a diagnosis of AAOCA (either referred to surgery or to medical follow-up )

Exclusion Criteria:

* isolated high-coronary take-off (≥ 5mm above sino-tubular junction), anomalous origin of a circumflex from the right coronary artery, anomalous course with a normal origin, and association to major congenital heart disease (i.e. Tetralogy of Fallot, transposition of the great arteries, anomalous origin of a coronary from the pulmonary artery).

Where it's running

  • Massimo Padalino
    Padova, Pd, Italy
    Recruiting
  • Christopher Grani
    Bern, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.